Triptans in Migraine

Peer Tfelt‐Hansen(University of Copenhagen), Peter de Vries, Pramod R. Saxena
Drugs
December 1, 2000
10.2165/00003495-200060060-00003
Cited by 523

Abstract

Related Papers

Oral Rizatriptan Versus Oral Sumatriptan: A Direct Comparative Study in the Acute Treatment of Migraine
Peer Tfelt‐Hansen, Judith Teall, Francisco Javier Rodríguez‐Gómez et al.|Headache The Journal of Head and Face Pain|1998|193
Sumatriptan
Greg L. Plosker, Donna McTavish|Drugs|1994|178
Sumatriptan
Caroline M. Perry, Anthony Markham|Drugs|1998|147
The pharmacology of the novel 5-HT1-like receptor agonist, GR43175.
P.P.A. Humphrey, W. Feniuk, M.J. Perren et al.|PubMed|1989|109
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
J.E. Leysen, W Gommeren, Lieve Heylen et al.|Molecular Pharmacology|1996|91